ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.659,45
0,50%
Dow Jones
40.935,97
1,80%
Euro vs US Dollar
1,08959
-0,03%
Bitcoin
64.938,58
0,13%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN

AstraZeneca (AZN)

AstraZeneca PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AZN
DatumZeitQuelleÜberschriftSymbolFirma
26/01/202108h47Dow Jones NewsAstraZeneca's Symbicort Approved in China for Mild AsthmaNASDAQ:AZNAstraZeneca PLC
25/01/202118h46Dow Jones NewsEU Calls AstraZeneca Response to Vaccine Delays UnsatisfactoryNASDAQ:AZNAstraZeneca PLC
25/01/202112h22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
25/01/202112h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
25/01/202108h44Dow Jones NewsAstraZeneca's Calquence Meets Goals in Leukemia TrialNASDAQ:AZNAstraZeneca PLC
23/01/202119h04Dow Jones NewsAstraZeneca's Covid-19 Vaccine Shortfall Threatens EU Plans to Boost InoculationsNASDAQ:AZNAstraZeneca PLC
22/01/202121h49Dow Jones NewsAstraZeneca Warns of Covid-19 Vaccine Shortfall in Europe -- UpdateNASDAQ:AZNAstraZeneca PLC
22/01/202121h20Dow Jones NewsAstraZeneca Warns of Covid-19 Vaccine Shortfall in EuropeNASDAQ:AZNAstraZeneca PLC
22/01/202120h09Dow Jones NewsAstraZeneca's Initial Vaccine Volumes in Europe to Be Lower Than ExpectedNASDAQ:AZNAstraZeneca PLC
20/01/202112h21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
20/01/202111h59Dow Jones NewsOxford-AstraZeneca's Covid-19 Vaccine Helps U.K. Lead Race to Reach Nursing HomesNASDAQ:AZNAstraZeneca PLC
20/01/202108h48Dow Jones NewsAstraZeneca Gets EU Approval for Breast Cancer TreatmentNASDAQ:AZNAstraZeneca PLC
18/01/202100h16Dow Jones NewsBrazil Starts Its Covid-19 Vaccine Rollout -- 4th UpdateNASDAQ:AZNAstraZeneca PLC
17/01/202120h24Dow Jones NewsBrazil Starts Its Covid-19 Vaccine Rollout -- 3rd UpdateNASDAQ:AZNAstraZeneca PLC
17/01/202120h06Dow Jones NewsBrazil Authorizes Use of Two Covid-19 Vaccines -- UpdateNASDAQ:AZNAstraZeneca PLC
17/01/202119h53Dow Jones NewsBrazil Authorizes Use of Two Covid-19 VaccinesNASDAQ:AZNAstraZeneca PLC
15/01/202113h31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
14/01/202117h03Dow Jones NewsCorrection to South Africa Skips National Regulatory Approval to Secure Covid-19 Vaccines Article on Jan. 7NASDAQ:AZNAstraZeneca PLC
12/01/202112h50Dow Jones NewsAstraZeneca Applies for European Clearance of Covid-19 VaccineNASDAQ:AZNAstraZeneca PLC
11/01/202122h01GlobeNewswire Inc.Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inf...NASDAQ:AZNAstraZeneca PLC
11/01/202119h55Dow Jones NewsGrail in Minimum Residual Disease Collaborations With Amgen, AstraZeneca, Bristol MyersNASDAQ:AZNAstraZeneca PLC
11/01/202114h12Dow Jones NewsEli Lilly, Twitter, NIO: What to Watch When the Stock Market Opens TodayNASDAQ:AZNAstraZeneca PLC
07/01/202120h47Dow Jones NewsSouth Africa Skips National Regulatory Approval to Secure Covid-19 Vaccines -- UpdateNASDAQ:AZNAstraZeneca PLC
07/01/202117h58Dow Jones NewsSouth Africa Skips National Regulatory Approval to Secure Covid-19 VaccinesNASDAQ:AZNAstraZeneca PLC
06/01/202112h27Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
06/01/202108h46Dow Jones NewsAstraZeneca's Chronic Kidney Disease Drug Granted US Priority ReviewNASDAQ:AZNAstraZeneca PLC
04/01/202117h15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
04/01/202112h37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
02/01/202117h22Dow Jones NewsIndia Approves Use of Oxford-AstraZeneca's Covid-19 VaccineNASDAQ:AZNAstraZeneca PLC
30/12/202022h27Dow Jones NewsU.K. Approves Covid-19 Vaccine Made by AstraZeneca, Oxford -- 9th UpdateNASDAQ:AZNAstraZeneca PLC
 Showing the most relevant articles for your search:NASDAQ:AZN

Kürzlich von Ihnen besucht

NASDAQ
TSLA
Tesla
AMEX
SPY
SPDR S&P 500
TG
ALV
Allianz
USOTC
ADDYY
Adidas (QX)
DBI
SDXP
SDAX
USOTC
BNPQY
BNP Paribas (QX)
TG
432
Arbor Metals
TG
DTE
Deutsche Telekom
NYSE
JPM
JP Morgan Chase
TG
BAS
BASF
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US30
US 30
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten